BBSRC invests £48m in Babraham Institute to advance lifelong health research
The funding will help to support research across epigenetics, immunology and cell signalling
Read Moreby Jen Brogan | May 13, 2024 | News | 0
The funding will help to support research across epigenetics, immunology and cell signalling
Read Moreby Jen Brogan | Apr 17, 2024 | News | 0
Both companies will facilitate career progression while advancing the life sciences industry
Read Moreby Jen Brogan | Mar 18, 2024 | News | 0
The centre will deliver free training, outreach materials and programmes
Read Moreby Jen Brogan | Aug 10, 2023 | News | 0
UBS Asset Management and Reef Group secure approval for the Stevenage-based facility
Read Moreby John Pinching | May 26, 2023 | News | 0
Life Sciences Council meeting hosted by chancellor Jeremy Hunt has unfolded in Downing Street
Read Moreby John Pinching | Feb 17, 2023 | News | 0
Company has reported strong momentum among the early-stage businesses it invested in last year
Read Moreby John Pinching | Aug 3, 2022 | News | 0
The sites will maximise local and global benefits of NHS, research, industry and community partnerships
Read Moreby John Pinching | Jun 30, 2022 | News | 0
Centre will accelerate drug development and enable precision health solutions
Read Moreby John Pinching | Apr 25, 2022 | News | 0
Novartis will provide vital volunteering projects, career plans for young people and financial support to local charities
Read Moreby John Pinching | Mar 2, 2022 | News | 0
The post-Brexit landscape has witnessed an exponential boom in life science careers
Read Moreby Lucy Parsons | Apr 23, 2021 | News | 0
Construction on Leiden, Netherlands site anticipated to begin later this year
Read Moreby Selina McKee | Apr 7, 2021 | News | 0
The £20 million fund will boost the UK’s life sciences manufacturing capabilities, creating new economic opportunities and highly skilled jobs
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479